세계의 코르티코스테로이드 API : 시장 점유율 및 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Corticosteroids API was estimated to be worth US$ 2421 million in 2024 and is forecast to a readjusted size of US$ 3645 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.

Corticosteroids Active Pharmaceutical Ingredients (APIs) are key raw materials used in the production of corticosteroid medications, which are widely utilized for their anti-inflammatory, immunosuppressive, and anti-allergic properties. These APIs include compounds such as hydrocortisone, prednisolone, dexamethasone, and betamethasone, which are essential in the treatment of conditions like asthma, rheumatoid arthritis, skin disorders, and autoimmune diseases. The production of corticosteroid APIs involves complex chemical synthesis and stringent quality control to ensure high purity, efficacy, and compliance with regulatory standards such as those set by the US FDA, EU EMA, and China NMPA. As demand for corticosteroid-based treatments continues to grow, particularly in dermatology, respiratory diseases, and organ transplantation, the corticosteroid API market remains a crucial segment within the pharmaceutical industry.

The corticosteroids API market has maintained stable growth in recent years, driven primarily by the pharmaceutical industry's demand. As a key component widely used in the treatment of inflammation, immunosuppression, dermatological conditions, and respiratory diseases, corticosteroids APIs continue to be in demand globally. Factors such as an aging population, rising prevalence of chronic diseases, and improvements in healthcare systems contribute to the increasing need for high-quality APIs. Additionally, the expansion of the generic drug industry has fueled market growth, particularly in emerging economies where policy support and the enhancement of local pharmaceutical capabilities are strengthening demand.

Looking ahead, the corticosteroids API market is expected to follow several key trends. Firstly, stricter environmental regulations are driving the need for greener and more compliant manufacturing processes, pushing companies to invest in R&D to reduce emissions and improve production efficiency. Secondly, as market competition intensifies, some high-end corticosteroid products will shift toward high-value generics following patent expirations, enabling differentiation strategies. Additionally, supply chain localization is becoming more prominent, with certain countries and regions strengthening their domestic API supply capabilities to reduce import dependency, impacting the global market structure. Furthermore, advancements in biotechnology may introduce new synthetic pathways and alternative therapies that could pose a challenge to the traditional corticosteroids API market.

Key growth drivers include rising medical demand, expansion of the global pharmaceutical industry, and policy support, particularly in emerging markets where governments encourage local production and offer tax incentives. Additionally, advancements in production technology, formulation innovations, and new indications are creating new growth opportunities. However, the industry faces challenges such as fluctuations in raw material prices, rising environmental compliance costs, and intense competition among leading manufacturers. Stricter global regulatory policies impose higher compliance requirements, potentially driving some companies out of the market. Moreover, increasing competition in the generics sector is putting pricing pressure on APIs, affecting overall profitability.

This report aims to provide a comprehensive presentation of the global market for Corticosteroids API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Corticosteroids API by region & country, by Type, and by Application.

The Corticosteroids API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroids API.

Market Segmentation

By Company

• Pfizer CentreOne
• EUROAPI
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• Hovione
• Axplora
• Steroid SpA
• Avik Pharmaceutical
• Anuh Pharma
• Symbiotec Pharmalab
• Sun Pharmaceutical
• Cipla
• Wellona Pharma
• Tianjin Tianyao Pharmaceuticals
• Zhejiang Xianju Pharmaceutical
• Guangdong VTR BioTech
• Zhejiang Xianju Xianle Pharmaceutical
• Tianjin Pacific Pharmaceutical
• Shandong Xinhua Pharmaceutica Group
• Jiangsu Lianhuan Pharmaceutical
• Shanghai New Hualian Pharmaceutical
• Shandong Taihua Biotech
• Shandong Sito Bio-technology
• Zhejiang Xianju Junye Pharmaceutical

Segment by Type

• Prednisone Series
• Dexamethasone Series
• Betamethasone Series
• Hydrocortisone Series
• Others

Segment by Application

• Injectable Drugs
• Oral Drugs
• Topical Drugs
• Inhaled Drugs

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Corticosteroids API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Corticosteroids API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Corticosteroids API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Corticosteroids API Product Introduction
• 1.2 Global Corticosteroids API Market Size Forecast
  • 1.2.1 Global Corticosteroids API Sales Value (2020-2031)
  • 1.2.2 Global Corticosteroids API Sales Volume (2020-2031)
  • 1.2.3 Global Corticosteroids API Sales Price (2020-2031)
• 1.3 Corticosteroids API Market Trends & Drivers
  • 1.3.1 Corticosteroids API Industry Trends
  • 1.3.2 Corticosteroids API Market Drivers & Opportunity
  • 1.3.3 Corticosteroids API Market Challenges
  • 1.3.4 Corticosteroids API Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Corticosteroids API Players Revenue Ranking (2024)
• 2.2 Global Corticosteroids API Revenue by Company (2020-2025)
• 2.3 Global Corticosteroids API Players Sales Volume Ranking (2024)
• 2.4 Global Corticosteroids API Sales Volume by Company Players (2020-2025)
• 2.5 Global Corticosteroids API Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Corticosteroids API Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Corticosteroids API Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Corticosteroids API
• 2.9 Corticosteroids API Market Competitive Analysis
  • 2.9.1 Corticosteroids API Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Corticosteroids API Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroids API as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Prednisone Series
  • 3.1.2 Dexamethasone Series
  • 3.1.3 Betamethasone Series
  • 3.1.4 Hydrocortisone Series
  • 3.1.5 Others
• 3.2 Global Corticosteroids API Sales Value by Type
  • 3.2.1 Global Corticosteroids API Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Corticosteroids API Sales Value, by Type (2020-2031)
  • 3.2.3 Global Corticosteroids API Sales Value, by Type (%) (2020-2031)
• 3.3 Global Corticosteroids API Sales Volume by Type
  • 3.3.1 Global Corticosteroids API Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Corticosteroids API Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Corticosteroids API Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Corticosteroids API Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Injectable Drugs
  • 4.1.2 Oral Drugs
  • 4.1.3 Topical Drugs
  • 4.1.4 Inhaled Drugs
• 4.2 Global Corticosteroids API Sales Value by Application
  • 4.2.1 Global Corticosteroids API Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Corticosteroids API Sales Value, by Application (2020-2031)
  • 4.2.3 Global Corticosteroids API Sales Value, by Application (%) (2020-2031)
• 4.3 Global Corticosteroids API Sales Volume by Application
  • 4.3.1 Global Corticosteroids API Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Corticosteroids API Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Corticosteroids API Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Corticosteroids API Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Corticosteroids API Sales Value by Region
  • 5.1.1 Global Corticosteroids API Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Corticosteroids API Sales Value by Region (2020-2025)
  • 5.1.3 Global Corticosteroids API Sales Value by Region (2026-2031)
  • 5.1.4 Global Corticosteroids API Sales Value by Region (%), (2020-2031)
• 5.2 Global Corticosteroids API Sales Volume by Region
  • 5.2.1 Global Corticosteroids API Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Corticosteroids API Sales Volume by Region (2020-2025)
  • 5.2.3 Global Corticosteroids API Sales Volume by Region (2026-2031)
  • 5.2.4 Global Corticosteroids API Sales Volume by Region (%), (2020-2031)
• 5.3 Global Corticosteroids API Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Corticosteroids API Sales Value, 2020-2031
  • 5.4.2 North America Corticosteroids API Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Corticosteroids API Sales Value, 2020-2031
  • 5.5.2 Europe Corticosteroids API Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Corticosteroids API Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Corticosteroids API Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Corticosteroids API Sales Value, 2020-2031
  • 5.7.2 South America Corticosteroids API Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Corticosteroids API Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Corticosteroids API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Corticosteroids API Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Corticosteroids API Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Corticosteroids API Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Corticosteroids API Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Corticosteroids API Sales Value, 2020-2031
  • 6.3.2 United States Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Corticosteroids API Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Corticosteroids API Sales Value, 2020-2031
  • 6.4.2 Europe Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Corticosteroids API Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Corticosteroids API Sales Value, 2020-2031
  • 6.5.2 China Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Corticosteroids API Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Corticosteroids API Sales Value, 2020-2031
  • 6.6.2 Japan Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Corticosteroids API Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Corticosteroids API Sales Value, 2020-2031
  • 6.7.2 South Korea Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Corticosteroids API Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Corticosteroids API Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Corticosteroids API Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Corticosteroids API Sales Value, 2020-2031
  • 6.9.2 India Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Corticosteroids API Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Pfizer CentreOne
  • 7.1.1 Pfizer CentreOne Company Information
  • 7.1.2 Pfizer CentreOne Introduction and Business Overview
  • 7.1.3 Pfizer CentreOne Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Pfizer CentreOne Corticosteroids API Product Offerings
  • 7.1.5 Pfizer CentreOne Recent Development
• 7.2 EUROAPI
  • 7.2.1 EUROAPI Company Information
  • 7.2.2 EUROAPI Introduction and Business Overview
  • 7.2.3 EUROAPI Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 EUROAPI Corticosteroids API Product Offerings
  • 7.2.5 EUROAPI Recent Development
• 7.3 GlaxoSmithKline
  • 7.3.1 GlaxoSmithKline Company Information
  • 7.3.2 GlaxoSmithKline Introduction and Business Overview
  • 7.3.3 GlaxoSmithKline Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 GlaxoSmithKline Corticosteroids API Product Offerings
  • 7.3.5 GlaxoSmithKline Recent Development
• 7.4 Teva Pharmaceutical Industries
  • 7.4.1 Teva Pharmaceutical Industries Company Information
  • 7.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
  • 7.4.3 Teva Pharmaceutical Industries Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Teva Pharmaceutical Industries Corticosteroids API Product Offerings
  • 7.4.5 Teva Pharmaceutical Industries Recent Development
• 7.5 Hovione
  • 7.5.1 Hovione Company Information
  • 7.5.2 Hovione Introduction and Business Overview
  • 7.5.3 Hovione Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Hovione Corticosteroids API Product Offerings
  • 7.5.5 Hovione Recent Development
• 7.6 Axplora
  • 7.6.1 Axplora Company Information
  • 7.6.2 Axplora Introduction and Business Overview
  • 7.6.3 Axplora Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Axplora Corticosteroids API Product Offerings
  • 7.6.5 Axplora Recent Development
• 7.7 Steroid SpA
  • 7.7.1 Steroid SpA Company Information
  • 7.7.2 Steroid SpA Introduction and Business Overview
  • 7.7.3 Steroid SpA Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Steroid SpA Corticosteroids API Product Offerings
  • 7.7.5 Steroid SpA Recent Development
• 7.8 Avik Pharmaceutical
  • 7.8.1 Avik Pharmaceutical Company Information
  • 7.8.2 Avik Pharmaceutical Introduction and Business Overview
  • 7.8.3 Avik Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Avik Pharmaceutical Corticosteroids API Product Offerings
  • 7.8.5 Avik Pharmaceutical Recent Development
• 7.9 Anuh Pharma
  • 7.9.1 Anuh Pharma Company Information
  • 7.9.2 Anuh Pharma Introduction and Business Overview
  • 7.9.3 Anuh Pharma Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Anuh Pharma Corticosteroids API Product Offerings
  • 7.9.5 Anuh Pharma Recent Development
• 7.10 Symbiotec Pharmalab
  • 7.10.1 Symbiotec Pharmalab Company Information
  • 7.10.2 Symbiotec Pharmalab Introduction and Business Overview
  • 7.10.3 Symbiotec Pharmalab Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Symbiotec Pharmalab Corticosteroids API Product Offerings
  • 7.10.5 Symbiotec Pharmalab Recent Development
• 7.11 Sun Pharmaceutical
  • 7.11.1 Sun Pharmaceutical Company Information
  • 7.11.2 Sun Pharmaceutical Introduction and Business Overview
  • 7.11.3 Sun Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Sun Pharmaceutical Corticosteroids API Product Offerings
  • 7.11.5 Sun Pharmaceutical Recent Development
• 7.12 Cipla
  • 7.12.1 Cipla Company Information
  • 7.12.2 Cipla Introduction and Business Overview
  • 7.12.3 Cipla Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Cipla Corticosteroids API Product Offerings
  • 7.12.5 Cipla Recent Development
• 7.13 Wellona Pharma
  • 7.13.1 Wellona Pharma Company Information
  • 7.13.2 Wellona Pharma Introduction and Business Overview
  • 7.13.3 Wellona Pharma Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Wellona Pharma Corticosteroids API Product Offerings
  • 7.13.5 Wellona Pharma Recent Development
• 7.14 Tianjin Tianyao Pharmaceuticals
  • 7.14.1 Tianjin Tianyao Pharmaceuticals Company Information
  • 7.14.2 Tianjin Tianyao Pharmaceuticals Introduction and Business Overview
  • 7.14.3 Tianjin Tianyao Pharmaceuticals Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Tianjin Tianyao Pharmaceuticals Corticosteroids API Product Offerings
  • 7.14.5 Tianjin Tianyao Pharmaceuticals Recent Development
• 7.15 Zhejiang Xianju Pharmaceutical
  • 7.15.1 Zhejiang Xianju Pharmaceutical Company Information
  • 7.15.2 Zhejiang Xianju Pharmaceutical Introduction and Business Overview
  • 7.15.3 Zhejiang Xianju Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Zhejiang Xianju Pharmaceutical Corticosteroids API Product Offerings
  • 7.15.5 Zhejiang Xianju Pharmaceutical Recent Development
• 7.16 Guangdong VTR BioTech
  • 7.16.1 Guangdong VTR BioTech Company Information
  • 7.16.2 Guangdong VTR BioTech Introduction and Business Overview
  • 7.16.3 Guangdong VTR BioTech Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Guangdong VTR BioTech Corticosteroids API Product Offerings
  • 7.16.5 Guangdong VTR BioTech Recent Development
• 7.17 Zhejiang Xianju Xianle Pharmaceutical
  • 7.17.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
  • 7.17.2 Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview
  • 7.17.3 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Product Offerings
  • 7.17.5 Zhejiang Xianju Xianle Pharmaceutical Recent Development
• 7.18 Tianjin Pacific Pharmaceutical
  • 7.18.1 Tianjin Pacific Pharmaceutical Company Information
  • 7.18.2 Tianjin Pacific Pharmaceutical Introduction and Business Overview
  • 7.18.3 Tianjin Pacific Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 Tianjin Pacific Pharmaceutical Corticosteroids API Product Offerings
  • 7.18.5 Tianjin Pacific Pharmaceutical Recent Development
• 7.19 Shandong Xinhua Pharmaceutica Group
  • 7.19.1 Shandong Xinhua Pharmaceutica Group Company Information
  • 7.19.2 Shandong Xinhua Pharmaceutica Group Introduction and Business Overview
  • 7.19.3 Shandong Xinhua Pharmaceutica Group Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 Shandong Xinhua Pharmaceutica Group Corticosteroids API Product Offerings
  • 7.19.5 Shandong Xinhua Pharmaceutica Group Recent Development
• 7.20 Jiangsu Lianhuan Pharmaceutical
  • 7.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
  • 7.20.2 Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview
  • 7.20.3 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Product Offerings
  • 7.20.5 Jiangsu Lianhuan Pharmaceutical Recent Development
• 7.21 Shanghai New Hualian Pharmaceutical
  • 7.21.1 Shanghai New Hualian Pharmaceutical Company Information
  • 7.21.2 Shanghai New Hualian Pharmaceutical Introduction and Business Overview
  • 7.21.3 Shanghai New Hualian Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.21.4 Shanghai New Hualian Pharmaceutical Corticosteroids API Product Offerings
  • 7.21.5 Shanghai New Hualian Pharmaceutical Recent Development
• 7.22 Shandong Taihua Biotech
  • 7.22.1 Shandong Taihua Biotech Company Information
  • 7.22.2 Shandong Taihua Biotech Introduction and Business Overview
  • 7.22.3 Shandong Taihua Biotech Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.22.4 Shandong Taihua Biotech Corticosteroids API Product Offerings
  • 7.22.5 Shandong Taihua Biotech Recent Development
• 7.23 Shandong Sito Bio-technology
  • 7.23.1 Shandong Sito Bio-technology Company Information
  • 7.23.2 Shandong Sito Bio-technology Introduction and Business Overview
  • 7.23.3 Shandong Sito Bio-technology Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.23.4 Shandong Sito Bio-technology Corticosteroids API Product Offerings
  • 7.23.5 Shandong Sito Bio-technology Recent Development
• 7.24 Zhejiang Xianju Junye Pharmaceutical
  • 7.24.1 Zhejiang Xianju Junye Pharmaceutical Company Information
  • 7.24.2 Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview
  • 7.24.3 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.24.4 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Product Offerings
  • 7.24.5 Zhejiang Xianju Junye Pharmaceutical Recent Development

8 Industry Chain Analysis

• 8.1 Corticosteroids API Industrial Chain
• 8.2 Corticosteroids API Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Corticosteroids API Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Corticosteroids API Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer